Hyaluronan Injections for Osteoarthritis of the Knee
Sodium hyaluronate (Hyalgan - Sanofi) and hylan G-F 20 (Synvisc - Wyeth- Ayerst) have been approved by the FDA for intra-articular injections in patients with knee pain due to osteoarthritis. Hylan G-F 20 is a cross-linked derivative of hyaluronic acid with a higher molecular weight than sodium hyaluronate. 'Hyaluronan' refers to either the acid or its salt....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Hyaluronan Injections for Osteoarthritis of the Knee
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1030
Article Code: 1030c
Date: July 3, 1998
Volume: 40
Pages: 69-70
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1030
Article Code: 1030c
Date: July 3, 1998
Volume: 40
Pages: 69-70
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)